European patent opposition outcomes in biotechnology.

D'Agostino, Lorena M.,; Tiraboschi, Lorenzo,; Torrisi, Salvatore,

doi:10.1016/j.wpi.2023.102185

European patent opposition outcomes in biotechnology.

D'Agostino, Lorena M., author.; Tiraboschi, Lorenzo, author.; Torrisi, Salvatore, author.

2023

格式

格式
BibTeX
MARCXML
TextMARC
MARC
DataCite
DublinCore
EndNote
NLM
RefWorks
RIS

Cite

详细记录

Title

European patent opposition outcomes in biotechnology.

Author

D'Agostino, Lorena M., author.
Tiraboschi, Lorenzo, author.
Torrisi, Salvatore, author.

项目类型

Journal article

描述

1 volume.

数字对象唯一标识符

https://doi.org/10.1016/j.wpi.2023.102185

摘要

Oppositions to patent grants are a means to attack competitors and protect a firm's own patent portfolio. Extant literature has analyzed the determinants of oppositions, while the drivers of opposition outcomes are less known. We study 290 EPO biotech patent oppositions filed in 2012–2019. There are three possible outcomes of opposition proceedings: patent revocation, patent amendment, and opposition rejection. We find that opponents who know the patent's technology are more likely to obtain a patent revocation, while opponents who compete in the product market with the patent owner are more likely to receive a rejection.

Source of Description

Crossref

丛编

World Patent Information ; 73, June, 2023.

发表于

World Patent Information

连续资源

online version

Published

Oxford [England] : Elsevier Ltd., 2023

语言

eng